|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.87 USD | -1.59% |
|
-4.89% | -59.85% |
| Capitalization | 4.24B 3.68B 3.46B 3.15B 5.82B 367B 6.56B 41.03B 15.7B 168B 15.91B 15.57B 618B | P/E ratio 2025 * |
-6.82x | P/E ratio 2026 * | -6.33x |
|---|---|---|---|---|---|
| Enterprise value | 4.24B 3.68B 3.46B 3.15B 5.82B 367B 6.56B 41.03B 15.7B 168B 15.91B 15.57B 618B | EV / Sales 2025 * |
-
| EV / Sales 2026 * | 170x |
| Free-Float |
97.87% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Vaxcyte, Inc.
More recommendations
More press releases
More news
| 1 day | -1.59% | ||
| 1 week | -4.89% | ||
| Current month | +1.17% | ||
| 1 month | -10.12% | ||
| 3 months | -55.86% | ||
| 6 months | -62.01% | ||
| Current year | -59.85% |
| 1 week | 32.54 |  | 34.94 |
| 1 month | 31.07 | | 38.39 |
| Current year | 27.66 | | 93.77 |
| 1 year | 27.66 | | 121.06 |
| 3 years | 19.36 | | 121.06 |
| 5 years | 15.51 | | 121.06 |
| 10 years | 15.51 | | 121.06 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeff Fairman
PRN | Corporate Officer/Principal | 61 | 2013-05-26 |
Grant Pickering
CEO | Chief Executive Officer | 57 | 2013-10-31 |
| Director of Finance/CFO | 55 | 2020-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Grant Pickering
BRD | Director/Board Member | 57 | 2013-10-31 |
Heath Lukatch
BRD | Director/Board Member | 57 | 2018-04-30 |
Halley Gilbert
BRD | Director/Board Member | 55 | 2020-03-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.59% | -4.89% | -54.82% | +62.80% | 4.24B | ||
| -0.75% | -3.69% | -51.19% | -12.26% | 53.86B | ||
| -0.44% | -6.27% | +31.34% | +44.60% | 33.16B | ||
| +0.52% | -4.39% | +58.85% | -33.33% | 26.05B | ||
| +2.04% | -0.04% | +24.05% | -14.87% | 26.23B | ||
| +3.24% | +4.00% | +58.68% | +452.64% | 19.5B | ||
| +1.98% | +3.94% | +163.59% | +1,997.75% | 15.27B | ||
| -1.78% | -7.02% | -23.37% | -31.97% | 13.11B | ||
| 0.00% | -13.93% | +105.63% | -64.40% | 12.49B | ||
| -0.91% | -2.93% | +85.78% | +117.51% | 11.01B | ||
| Average | +0.34% | -3.55% | +39.85% | +251.85% | 21.49B | |
| Weighted average by Cap. | +0.58% | -3.30% | +27.05% | +182.52% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | - | 25M 21.68M 20.43M 18.56M 34.34M 2.17B 38.69M 242M 92.57M 992M 93.81M 91.81M 3.65B |
| Net income | -658M -571M -538M -489M -904M -57.01B -1.02B -6.37B -2.44B -26.11B -2.47B -2.42B -96B | -738M -640M -603M -548M -1.01B -63.94B -1.14B -7.14B -2.73B -29.29B -2.77B -2.71B -108B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
414
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-20 | 32.87 $ | -1.59% | 2,520,873 |
| 25-06-18 | 33.40 $ | -0.71% | 892,461 |
| 25-06-17 | 33.64 $ | -2.01% | 899,044 |
| 25-06-16 | 34.33 $ | -0.67% | 1,026,102 |
| 25-06-13 | 34.56 $ | +0.29% | 1,208,351 |
Delayed Quote Nasdaq, June 20, 2025 at 04:00 pm EDT
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
32.87USD
Average target price
125.75USD
Spread / Average Target
+282.57%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PCVX Stock
Select your edition
All financial news and data tailored to specific country editions
